Hope vs. Hype I: Spreading alpha-synuclein explains cognitive deficits in Parkinson disease

Kelly A. Mills, Oliver Phillips, Abhimanyu Mahajan

Research output: Contribution to journalComment/debatepeer-review

Abstract

The Parkinson Study Group (PSG) gathered North American experts in Parkinson disease during the 9th Annual Symposium on “Shaping the Management of Parkinson Disease: Debating Current Controversies”. Debaters were tasked with agree or disagree positions to a particular prompt. This is the first in three-part series of “Hype vs. Hope” debates involving current trends and advances in Parkinson disease. With the prompt of “Spreading alpha-synuclein explains cognitive deficits in Parkinson disease,” Dr. Kelly Mills, MD, MHS was tasked with the “agree” stance and Dr. Abhimanyu Mahajan, MD, MHS was tasked with the “disagree” stance.

Original languageEnglish (US)
Article number106042
JournalParkinsonism and Related Disorders
DOIs
StateAccepted/In press - 2024

Keywords

  • Alpha-synuclein
  • Amyloid
  • Cognition
  • Dementia
  • Parkinson disease

ASJC Scopus subject areas

  • Neurology
  • Geriatrics and Gerontology
  • Clinical Neurology

Cite this